SCHEMBL6666416

SCHEMBL6666416

NC(CCC(N)CCC(N)CC(=O)O)CCC(N)CC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPEP Q07075 6/20 0.46
ANPEP P15144 3/20 0.46
SLC22A6 Q4U2R8 1/20 0.43
S1PR2 O95136 1/20 0.43
S1PR1 P21453 1/20 0.43
GABRR1 P24046 2/20 0.42
LMNA P02545 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
GABRP O00591 2/20 0.40
GABRD O14764 2/20 0.40
GABRA1 P14867 2/20 0.40
GABRB1 P18505 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA5 P31644 2/20 0.40
GABRA3 P34903 2/20 0.40
GABRA2 P47869 2/20 0.40
GABRB2 P47870 2/20 0.40
GABRA4 P48169 2/20 0.40
GABRE P78334 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6664634 1.00 ENPEP (0.46) ENPEPANPEPSLC22A6S1PR2S1PR1
SCHEMBL6893911 0.88 GABRP (0.54) ENPEPANPEPSLC22A6S1PR2S1PR1
SCHEMBL6898945 0.88 GABRP (0.54) ENPEPANPEPSLC22A6S1PR2S1PR1
SCHEMBL28799207 0.88 SLC22A6 (0.47) ENPEPANPEPSLC22A6S1PR2S1PR1
SCHEMBL18676125 0.87 SLC22A6 (0.43) ENPEPANPEPSLC22A6S1PR2S1PR1
SCHEMBL3994890 0.86 GABRP (0.41) ENPEPANPEPSLC22A6S1PR2S1PR1
SCHEMBL3994937 0.86 GABRP (0.41) ENPEPANPEPSLC22A6S1PR2S1PR1
SCHEMBL4000950 0.86 GABRP (0.41) ENPEPANPEPSLC22A6S1PR2S1PR1
SCHEMBL9223551 0.85 GSR (0.56) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL288992 0.85 SLC1A3 (0.45) ENPEPANPEPSLC22A6S1PR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0910331-B1 OXA DIACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PROD INC (US) 2004-09-08 EP claimed
EP-0910331-A4 OXA DIACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PROD INC (US) 1999-11-03 EP claimed
EP-0910331-A1 OXA DIACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PRODUCTS, INC. (US) 1999-04-28 EP claimed
US-5834513-A TOPICAL COMPOSITION FOR TREATING SKIN CONDITIONS CHARACTERIZED BY ABNORMAL DESQUAMATION AVON PRODUCTS, INC. (US) 1998-11-10 US claimed
WO-1997039726-A1 OXA DIACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PRODUCTS, INC. (US) 1997-10-30 WO claimed
EP-0910331-B1 OXA DIACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PROD INC (US) 2004-09-08 EP disclosed
EP-0910331-A4 OXA DIACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PROD INC (US) 1999-11-03 EP disclosed
US-5932229-A TOPICAL COMPOUNDS AVON PRODUCTS, INC. (US) 1999-08-03 US disclosed
EP-0910331-A1 OXA DIACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PRODUCTS, INC. (US) 1999-04-28 EP disclosed
US-5834513-A TOPICAL COMPOSITION FOR TREATING SKIN CONDITIONS CHARACTERIZED BY ABNORMAL DESQUAMATION AVON PRODUCTS, INC. (US) 1998-11-10 US disclosed
WO-1997039726-A1 OXA DIACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PRODUCTS, INC. (US) 1997-10-30 WO disclosed